Patents by Inventor Lynda M. Sanders

Lynda M. Sanders has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Intranasal administration of polypeptides in powdered form
    Patent number: 6815424
    Abstract: Pharmaceutical compositions of biologically active polypeptides in powder form suitable for nasal administration, comprising a therapeutically effective amount of a biologically active polypeptide and a water-soluble polysaccharide.
    Type: Grant
    Filed: December 23, 2002
    Date of Patent: November 9, 2004
    Assignee: Pfizer Corporation
    Inventors: Brian H. Vickery, Eric J. Benjamin, Cherng-Chyi Fu, Lynda M. Sanders
  • Therapeutic compositions for drug delivery to and through covering epithelia
    Publication number: 20040151774
    Abstract: Polymer foams and films for delivery of therapeutic agents to and through nasal, oral or vaginal mucosa and cornified or non-cornified epithelium of labia and scrotum. Polymer foams or absorbable or non-absorbable films containing a therapeutic agent incorporated therein wherein said agent is released from said foams or films upon placement of said foam or film on the surface epithelium of nasal, oral, or vaginal labia or scrotum. The foam or the film has a controllable rate of gelling, swelling and degradation and is preformed into a device or is applied as a coating to a surface of a more complex drug delivery system.
    Type: Application
    Filed: October 31, 2003
    Publication date: August 5, 2004
    Inventors: Giovanni M. Pauletti, Kishorkumar J. Desai, Susan L. Roweton, Donald C. Harrison, Lynda M. Sanders
  • Intranasal administration of polypeptides in powdered form
    Publication number: 20030181387
    Abstract: Pharmaceutical compositions of biologically active polypeptides in powder form suitable for nasal administration, comprising a therapeutically effective amount of a biologically active polypeptide and a water-soluble polysaccharide.
    Type: Application
    Filed: December 23, 2002
    Publication date: September 25, 2003
    Inventors: Brian H. Vickery, Eric J. Benjamin, Cherng-Chyi Fu, Lynda M. Sanders
  • Intranasal administration of LHRH polypeptides in powdered form
    Patent number: 6521597
    Abstract: Pharmaceutical compositions of biologically active polypeptides in powder form suitable for nasal administration, comprising a therapeutically effective amount of a biologically active polypeptide and a water-soluble polysaccharide.
    Type: Grant
    Filed: June 19, 1992
    Date of Patent: February 18, 2003
    Assignee: Pharmacia Corporation
    Inventors: Brian H. Vickery, Eric J. Benjamin, Cherng-Chyi Fu, Lynda M. Sanders
  • Delivery systems for the controlled administration of LHRH analogs
    Patent number: 5028430
    Abstract: An implantable polymeric delivery system for the controlled and continuous administration of an LHRH agonist which comprises a silicone elastomer matrix in which is dispersed about 30 to about 42 weight percent of water-soluble particulate phase containing an LHRH analog or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: May 8, 1987
    Date of Patent: July 2, 1991
    Assignee: Syntex (U.S.A.) Inc.
    Inventors: Lynda M. Sanders, Ramon A. Burns, Jr.
  • Delayed/sustained release of macromolecules
    Patent number: 4959217
    Abstract: This invention concerns novel, delayed/sustained release devices and compositions, including methods of their manufacture and use. The compositions include macromolecules, particularly polypeptide pharmaceuticals, and an initially partially-hydrated, non-biodegradable, hydrogel rate-limiting membrane.
    Type: Grant
    Filed: May 22, 1986
    Date of Patent: September 25, 1990
    Assignee: Syntex (U.S.A.) Inc.
    Inventors: Lynda M. Sanders, Abraham Domb
  • Microencapsulation of water soluble active polypeptides
    Patent number: 4675189
    Abstract: This invention concerns novel sustained release microcapsule compositions comprising water-soluble, hormonally active polypeptides and, optionally, a polymer hydrolysis modifying agent encapsulated in a biocompatible, biodegradable polymer.
    Type: Grant
    Filed: February 8, 1985
    Date of Patent: June 23, 1987
    Assignee: Syntex (U.S.A.) Inc.
    Inventors: John S. Kent, Danny H. Lewis, Lynda M. Sanders, Thomas R. Tice